DE69929530D1 - Attenuierte pferdeherpesvirus - Google Patents

Attenuierte pferdeherpesvirus

Info

Publication number
DE69929530D1
DE69929530D1 DE69929530T DE69929530T DE69929530D1 DE 69929530 D1 DE69929530 D1 DE 69929530D1 DE 69929530 T DE69929530 T DE 69929530T DE 69929530 T DE69929530 T DE 69929530T DE 69929530 D1 DE69929530 D1 DE 69929530D1
Authority
DE
Germany
Prior art keywords
ehv
mutants
relates
attenuated
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69929530T
Other languages
English (en)
Other versions
DE69929530T2 (de
Inventor
Jacobus Sondermeijer
Nicolaas Visser
Rachel Dhore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69929530D1 publication Critical patent/DE69929530D1/de
Publication of DE69929530T2 publication Critical patent/DE69929530T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16411—Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16461—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69929530T 1998-07-31 1999-07-26 Attenuierter pferdeherpesvirus Expired - Lifetime DE69929530T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98202594 1998-07-31
EP98202594 1998-07-31
PCT/EP1999/005476 WO2000008165A1 (en) 1998-07-31 1999-07-26 Attenuated equine herpesvirus

Publications (2)

Publication Number Publication Date
DE69929530D1 true DE69929530D1 (de) 2006-04-06
DE69929530T2 DE69929530T2 (de) 2006-07-20

Family

ID=8234001

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929530T Expired - Lifetime DE69929530T2 (de) 1998-07-31 1999-07-26 Attenuierter pferdeherpesvirus

Country Status (9)

Country Link
US (1) US7060282B1 (de)
EP (1) EP1100925B1 (de)
AT (1) ATE316139T1 (de)
AU (1) AU758604B2 (de)
BR (1) BR9912626B1 (de)
CA (1) CA2337965C (de)
DE (1) DE69929530T2 (de)
HU (1) HUP0102861A3 (de)
WO (1) WO2000008165A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (de) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos
WO2005063991A2 (en) 2003-12-19 2005-07-14 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine
US7722860B2 (en) 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
EP2247307A1 (de) * 2007-12-21 2010-11-10 GlaxoSmithKline Biologicals S.A. Impfstoff
AU2009277107B2 (en) * 2008-07-30 2014-02-27 University Of Kentucky Research Foundation Equine disease model for herpesvirus neurologic disease and uses thereof
HUE033739T2 (en) * 2010-10-18 2018-01-29 Intervet Int Bv Turkey herpesvirus vector vaccine against avian influenza in poultry
CA3036293A1 (en) 2016-09-20 2018-03-29 Boehringer Ingelheim Vetmedica Gmbh New promoters
UY37406A (es) 2016-09-20 2018-03-23 Boehringer Ingelheim Vetmedica Gmbh Nuevo sitio de inserción orf70 de ehv
CN109715219B (zh) 2016-09-20 2024-03-01 勃林格殷格翰动物保健有限公司 犬腺病毒载体
EP3515480A1 (de) * 2016-09-20 2019-07-31 Boehringer Ingelheim Vetmedica GmbH Neuer schweinegrippenimpfstoff

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014951D0 (en) 1990-07-06 1990-08-29 Univ Glasgow Equine herpesvirus-4 tk vaccine
GB9415319D0 (en) 1994-07-29 1994-09-21 Medical Res Council HSV viral vector

Also Published As

Publication number Publication date
DE69929530T2 (de) 2006-07-20
EP1100925A1 (de) 2001-05-23
BR9912626B1 (pt) 2010-09-08
CA2337965C (en) 2009-12-15
WO2000008165A1 (en) 2000-02-17
AU5729399A (en) 2000-02-28
ATE316139T1 (de) 2006-02-15
BR9912626A (pt) 2001-04-24
AU758604B2 (en) 2003-03-27
EP1100925B1 (de) 2006-01-18
HUP0102861A3 (en) 2005-03-29
US7060282B1 (en) 2006-06-13
HUP0102861A2 (hu) 2001-11-28
CA2337965A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
DE69535359D1 (de) Rekombinantes herpesvirus aus trufhähnen und seine verwendungen
DE69929530D1 (de) Attenuierte pferdeherpesvirus
DK0707071T3 (da) Rekombinante vektorer afledt fra adenovirus til anvendelse i genterapi
BR9205771A (pt) Vetor de vírus recombinantes e processo para a fabricaçao do mesmo
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
YU6304A (sh) Atenuirani virus besnila sa nukleoproteinskom mutacijom u mestu za fosforilaciju za vakcinaciju protiv besnila i gensku terapiju u cns-u
ATE346931T1 (de) Clostridium perfringens impfstoff
DK0507179T3 (da) Equine herpesvira (EHV), der indeholder fremmed
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
BR9909173A (pt) ácido nucleico, mutante de deleção de um alfa-vìrus, adenovìrus recombinante, vìrus vacìnia recombinante, plasmìdeo, vacina, e, processo para produzir uma imune resposta protetora a um alfa-vìrus
Elahi et al. Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses
AP2000001892A0 (en) Self-replicating vector for DNA immunization against HIV.
DE69333074D1 (de) Rekombitante, equine herpesviren
NO20005482D0 (no) Rekombinant virus som uttrykker fremmed DNA som koder for Felin CD80, Felin CTLA-4 eller Felin CD86 og anvendelse derav
HUP9904201A1 (hu) Génterápiában használható, egy exogén nukleinsavat genomjában beépítve tartalmazó rekombináns vírus és egy nem virális és nem plazmid transzfektáló szer kombinációját tartalmazó transzfektáló készítmény
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
WO2004039400A3 (en) Bhv5 mutants
Yamada et al. Deletion of gene OV132 attenuates Orf virus more effectively than gene OV112
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL